Member Directory
KISS - the multiplier agency.
An award-winning B2B marketing agency where expertise meets an unwavering desire for exceptional results. If you’re ambitious about multiplying the impact of your marketing performance, we are the agency to help your grow your business.
Fuelled by a team of experts across strategy, creativity, technology and performance, we will amplify your marketing performance and grow your business through our theory of multiplication: Creativity x Technology x Data.
We harness the power of creativity to ensure you stand out in the marketplace, enabling this with the latest technology. Everything we do is informed by data to deliver your message through the right channels, to the right audiences, at the right time to deliver maximum impact.
From concept to completion, our projects multiply results.
Growth is good. Multiplying is better.
Korecyte Bio is a preclinical biotech startup incorporated in 2023 in NL (Korecyte Bio BV) and in the UK (Korecyte Innovations Ltd.) The company has developed a genetic switching platform that can be fused to any CAR-based cell therapeutic, like CAR-T, as a stringent tumour-selective switch that can render the cells much safer and more effective in attacking a solid tumour.
Kymab is a biopharmaceutical company using a proprietary transgenic antibody platform, Kymouse, to discover and develop fully human monoclonal antibody drugs. The technology used to design the Kymouse strains originated from the Wellcome Trust Sanger Institute in Cambridge, UK. Kymouse™ has been designed to maximise the diversity of human antibodies produced in response to immunisation. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding that rare drug candidate with best-in-class characteristics.
Leaf Expression Systems is a new contract development business specialising in the plant-based expression and production of proteins, metabolites and complex natural products for research and biomedical applications using a proprietary, transient expression technology, Hypertrans®.
Watch our Member Showcase Video https://bit.ly/3nGHUEV
With over 25 years' of expertise in the IVD Industry, we are dedicated to helping businesses in launching new and innovative diagnostic products.
Founded in 2023, Lehane Consulting Ltd offers unparalleled medical diagnostic knowledge to companies developing diagnostic tools that enhance and innovate healthcare. With 70% of NHS clinical decisions relying on Laboratory or Point of Care tests, such results are pivotal for accurate diagnoses, commencing effective treatments, and comprehensive patient management. Navigating the market introduction of diagnostic tests is complex; therefore, Lehane Consulting delivers essential advice, guidance and support for product development, market analysis, clinical study design, and medical communications throughout your product's lifecycle.
Contact us at Lucy@lehaneconsulting.co.uk, visit our website at www.lehaneconsulting.co.uk, or follow us on Twitter @LehaneConsult.
LEX Diagnostics is a spin out from TTP plc, a leading technology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. We formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. . The new name reflects the charity’s purpose: to be the arc or bridge between research and improving patients’ lives.. . LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. . . So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance. . . www.lifearc.org Twitter @lifearc1.